ATP2B3, and KCNJ5 Mutations in Aldosterone-Producing Adenomas

Aldosterone ‐ producing adenomas (APAs) cause a sporadic form of primary aldosteronism and somatic mutations in the KCNJ5 gene, which encodes the G ‐ protein–activated inward rectifier K + channel 4, GIRK4, account for ≈ 40% of APAs. Additional somatic APA mutations were identified recently in 2 other genes, ATP1A1 and ATP2B3 , encoding Na + /K + ‐ ATPase 1 and Ca 2+ ‐ ATPase 3, respectively, at a combined prevalence of 6.8%. We have screened 112 APAs for mutations in known hotspots for genetic alterations associated with primary aldosteronism. Somatic mutations in ATP1A1 , ATP2B3 , and KCNJ5 were present in 6.3%, 0.9%, and 39.3% of APAs, respectively, and included 2 novel mutations (Na + /K + ‐ ATPase p.Gly99Arg and GIRK4 p.Trp126Arg). CYP11B2 gene expression was higher in APAs harboring ATP1A1 and ATP2B3 mutations compared with those without these or KCNJ5 mutations. Overexpression of Na + /K + ‐ ATPase p.Gly99Arg and GIRK4 p.Trp126Arg in HAC15 adrenal cells resulted in upregulation of CYP11B2 gene expression and its transcriptional regulator NR4A2. Structural modeling of the Na + /K + ‐ ATPase showed that the Gly99Arg substitution most likely interferes with the gateway to the ion binding pocket. In vitro functional assays demonstrated that Gly99Arg displays severely impaired ATPase activity, a reduced apparent affinity for Na + activation of phosphorylation and K + inhibition of phosphorylation that indicate decreased Na + and K + binding, respectively. Moreover, whole cell patch ‐ clamp studies established that overexpression of Na + /K + ‐ ATPase Gly99Arg causes membrane voltage depolarization. In conclusion, somatic mutations are common in APAs that result in an increase in CYP11B2 gene expression and may account for the dysregulated aldosterone production in a subset of patients with sporadic primary aldosteronism. mutation is likely to cause a steric clash with an impact on surrounding residues, including Glu334 that binds K + . Consistently, we show that the p.Gly99Arg mutant displayed minimal ATPase activity, reduced Na + affinity, and markedly reduced K + affinity when compared with the wild ‐ type ATPase as observed in phosphorylation studies. These results are in agreement with a disturbed gating mechanism, in particular, affecting K + binding to the mutated pump. Adrenal zona glomerulosa cells display a distinctive high resting K + conductance that maintains the high negative membrane potential ( − 80 mV) of these cells. 26 We demonstrate by whole cell patch ‐ clamp studies that the p.Gly99Arg mutation results in the depolarization of the membrane voltage. In adrenal glomerulosa cells, this depolarization results in the opening of voltage ‐ gated Ca 2+ channels. 2,8 In accordance with an increase in Ca 2+ influx, we show that the overexpression of p.Gly99Arg or p.Leu104Arg in adrenal cells results in an increase in CYP11B2 gene expression and also, for the p.Gly99Arg mutation, NR4A2 . Finally, the expression of CYP11B2 in APAs harboring ATPase mutations was significantly higher compared with those without these or GIRK4 mutations; an effect of heterozygous ATPase mutations on glomerulosa cells is consistent with the unique sensitivity of these cells to small changes in intracellular K + and membrane potential. 26,27 Taken together, these observations are in agreement with a pathophysiological link between the presence of these mutations and the dysregulated aldosterone secretion in patients with APA.

[1]  M. Zennaro,et al.  KCNJ5 mutations in aldosterone producing adenoma and relationship with adrenal cortex remodeling , 2013, Molecular and Cellular Endocrinology.

[2]  T. Wieland,et al.  Somatic mutations in ATP1A1 and ATP2B3 lead to aldosterone-producing adenomas and secondary hypertension , 2013, Nature Genetics.

[3]  F. Veglio,et al.  Role of KCNJ5 in familial and sporadic primary aldosteronism , 2013, Nature Reviews Endocrinology.

[4]  Morris J. Brown,et al.  Characterization of a novel somatic KCNJ5 mutation delI157 in an aldosterone-producing adenoma , 2012, Journal of hypertension.

[5]  M. Bäckdahl,et al.  Comprehensive Re-Sequencing of Adrenal Aldosterone Producing Lesions Reveal Three Somatic Mutations near the KCNJ5 Potassium Channel Selectivity Filter , 2012, PloS one.

[6]  R. Bollag,et al.  Effect of KCNJ5 mutations on gene expression in aldosterone-producing adenomas and adrenocortical cells. , 2012, The Journal of clinical endocrinology and metabolism.

[7]  F. Veglio,et al.  Visinin-Like 1 Is Upregulated in Aldosterone-Producing Adenomas With KCNJ5 Mutations and Protects From Calcium-Induced Apoptosis , 2012, Hypertension.

[8]  Morris J. Brown,et al.  Microarray, qPCR, and KCNJ5 sequencing of aldosterone-producing adenomas reveal differences in genotype and phenotype between zona glomerulosa- and zona fasciculata-like tumors. , 2012, The Journal of clinical endocrinology and metabolism.

[9]  F. Beuschlein,et al.  Prevalence, Clinical, and Molecular Correlates of KCNJ5 Mutations in Primary Aldosteronism , 2012, Hypertension.

[10]  C. Gomez-Sanchez,et al.  Potassium channel mutant KCNJ5 T158A expression in HAC-15 cells increases aldosterone synthesis. , 2012, Endocrinology.

[11]  T. Strom,et al.  KCNJ5 Mutations in European Families With Nonglucocorticoid Remediable Familial Hyperaldosteronism , 2012, Hypertension.

[12]  S. Mane,et al.  K+ Channel Mutations in Adrenal Aldosterone-Producing Adenomas and Hereditary Hypertension , 2011, Science.

[13]  A. Sapino,et al.  Teratocarcinoma-Derived Growth Factor-1 Is Upregulated in Aldosterone-Producing Adenomas and Increases Aldosterone Secretion and Inhibits Apoptosis In Vitro , 2010, Hypertension.

[14]  J. Barhanin,et al.  TASK1 and TASK3 Potassium Channels: Determinants of Aldosterone Secretion and Adrenocortical Zonation , 2010, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[15]  W. Rainey,et al.  Role of angiotensin II-induced rapid response genes in the regulation of enzymes needed for aldosterone synthesis. , 2008, Journal of molecular endocrinology.

[16]  W. Young,et al.  Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline. , 2008, The Journal of clinical endocrinology and metabolism.

[17]  F. Veglio,et al.  Roles of clinical criteria, computed tomography scan, and adrenal vein sampling in differential diagnosis of primary aldosteronism subtypes. , 2008, The Journal of clinical endocrinology and metabolism.

[18]  P. Nissen,et al.  Crystal structure of the sodium–potassium pump , 2007, Nature.

[19]  A. P. Einholm,et al.  Importance of Leu99 in Transmembrane Segment M1 of the Na+,K+-ATPase in the Binding and Occlusion of K+* , 2007, Journal of Biological Chemistry.

[20]  A. P. Einholm,et al.  Mutation of Gly-94 in transmembrane segment M1 of Na+,K+-ATPase interferes with Na+ and K+ binding in E2P conformation. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[21]  A. Spät Glomerulosa cell—a unique sensor of extracellular K+ concentration , 2004, Molecular and Cellular Endocrinology.

[22]  J. Davis,et al.  Insights into the mechanism by which inhibition of Na,K-ATPase stimulates aldosterone production. , 1999, Metabolism: clinical and experimental.

[23]  M. Lazdunski,et al.  A neuronal two P domain K+ channel stimulated by arachidonic acid and polyunsaturated fatty acids , 1998, The EMBO journal.

[24]  R. Newcombe Two-sided confidence intervals for the single proportion: comparison of seven methods. , 1998, Statistics in medicine.

[25]  L. Hunyady,et al.  Angiotensin-II inhibits Na+/K+ pump in rat adrenal glomerulosa cells: possible contribution to stimulation of aldosterone production. , 1992, Endocrinology.

[26]  J. Kaplan,et al.  Biochemistry of Na,K-ATPase. , 2002, Annual review of biochemistry.